163 related articles for article (PubMed ID: 8303299)
21. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
Raine CS; Bonetti B; Cannella B
Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
[TBL] [Abstract][Full Text] [Related]
22. Cloning and expression analysis of the murine lymphotoxin beta gene.
Pokholok DK; Maroulakou IG; Kuprash DV; Alimzhanov MB; Kozlov SV; Novobrantseva TI; Turetskaya RL; Green JE; Nedospasov SA
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):674-8. PubMed ID: 7846035
[TBL] [Abstract][Full Text] [Related]
23. An invertebrate defense molecule activates membrane conductance in mammalian cells by means of its lectin-like domain.
Bloc A; Lucas R; Van Dijck E; Bilej M; Dunant Y; De Baetselier P; Beschin A
Dev Comp Immunol; 2002 Jan; 26(1):35-43. PubMed ID: 11687261
[TBL] [Abstract][Full Text] [Related]
24. IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysis in the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation.
Reddy J; Chastagner P; Fiette L; Liu X; Thèze J
Int Immunol; 2001 Feb; 13(2):135-47. PubMed ID: 11157847
[TBL] [Abstract][Full Text] [Related]
25. Lymphotoxin lacks effects on 75-kDa receptors in cytotoxicity on U-937 cells.
Iwamoto S; Shibuya I; Takeda K; Takeda M
Biochem Biophys Res Commun; 1994 Feb; 199(1):70-7. PubMed ID: 8123048
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes.
Karpusas M; Cachero TG; Qian F; Boriack-Sjodin A; Mullen C; Strauch K; Hsu YM; Kalled SL
J Mol Biol; 2002 Feb; 315(5):1145-54. PubMed ID: 11827482
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
Andrews JS; Berger AE; Ware CF
J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
[TBL] [Abstract][Full Text] [Related]
28. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands.
Hochman PS; Majeau GR; Mackay F; Browning JL
J Inflamm; 1995-1996; 46(4):220-34. PubMed ID: 8878796
[TBL] [Abstract][Full Text] [Related]
29. Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein.
Gray PW; Barrett K; Chantry D; Turner M; Feldmann M
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7380-4. PubMed ID: 2170974
[TBL] [Abstract][Full Text] [Related]
30. Membrane lymphotoxin is required for resistance to Theiler's virus infection.
Lin X; Ma X; Rodriguez M; Feng X; Zoecklein L; Fu YX; Roos RP
Int Immunol; 2003 Aug; 15(8):955-62. PubMed ID: 12882833
[TBL] [Abstract][Full Text] [Related]
31. Lymphotoxin and TNF differ greatly in capacity to induce differentiation of human myeloblastic leukemia ML-1 cells.
Takeda K; Iwamoto S; Takeda M
Biochem Mol Biol Int; 1994 Apr; 32(6):1109-19. PubMed ID: 8061628
[TBL] [Abstract][Full Text] [Related]
32. Specific uptake of tumor necrosis factor-alpha is involved in growth control of Trypanosoma brucei.
Magez S; Geuskens M; Beschin A; del Favero H; Verschueren H; Lucas R; Pays E; de Baetselier P
J Cell Biol; 1997 May; 137(3):715-27. PubMed ID: 9151676
[TBL] [Abstract][Full Text] [Related]
33. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients.
Gatanaga T; Hwang CD; Kohr W; Cappuccini F; Lucci JA; Jeffes EW; Lentz R; Tomich J; Yamamoto RS; Granger GA
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8781-4. PubMed ID: 2174164
[TBL] [Abstract][Full Text] [Related]
34. [Comparative study of the effect of recombinant tumor necrosis factor and synthetic peptides, corresponding to its fragments, on phagocytosis,mediated by Fc- and MF-receptors].
Koniaev IG; Freĭdlin IS; Maĭrov VA; Zav'ialov VP
Biull Eksp Biol Med; 1996 Mar; 121(3):304-8. PubMed ID: 8688535
[No Abstract] [Full Text] [Related]
35. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization.
Rennert PD; Browning JL; Hochman PS
Int Immunol; 1997 Nov; 9(11):1627-39. PubMed ID: 9418124
[TBL] [Abstract][Full Text] [Related]
36. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.
Estrov Z; Kurzrock R; Pocsik E; Pathak S; Kantarjian HM; Zipf TF; Harris D; Talpaz M; Aggarwal BB
J Exp Med; 1993 Mar; 177(3):763-74. PubMed ID: 8382256
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor alpha and lymphotoxin stimulate human myeloblastic leukemia cell (ML-1) invasion through a reconstituted basement membrane (Matrigel) with concomitant induction of 92 kDa gelatinase secretion.
Kubota S; Takeda K; Yamada T; Nomura Y; Takeda M; Iwamoto S; Seyama Y
Cancer Lett; 1996 Jan; 98(2):233-40. PubMed ID: 8556714
[TBL] [Abstract][Full Text] [Related]
38. Mapping protein-protein contact sites using cellulose-bound peptide scans.
Reineke U; Sabat R; Kramer A; Stigler RD; Seifert M; Michel T; Volk HD; Schneider-Mergener J
Mol Divers; 1996 May; 1(3):141-8. PubMed ID: 9237205
[TBL] [Abstract][Full Text] [Related]
39. Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha.
Smith CA; Hu FQ; Smith TD; Richards CL; Smolak P; Goodwin RG; Pickup DJ
Virology; 1996 Sep; 223(1):132-47. PubMed ID: 8806547
[TBL] [Abstract][Full Text] [Related]
40. Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer.
Cappuccini F; Yamamoto RS; DiSaia PJ; Grosen EA; Gatanaga M; Lucci JA; Ininns EK; Gatanaga T; Granger GA
Lymphokine Cytokine Res; 1991 Jun; 10(3):225-9. PubMed ID: 1653048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
